Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia

Clin Endocrinol (Oxf). 2009 Oct;71(4):470-6. doi: 10.1111/j.1365-2265.2008.03517.x. Epub 2008 Dec 17.

Abstract

Background: More than 90% of all cases of congenital adrenal hyperplasia (CAH) result from steroid 21-hydroxylase gene (CYP21A2) mutations. Most of these mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P pseudogene. Rare mutations not generated by gene conversion account for 5-10% of 21-hydroxylase deficiency alleles.

Objective: Functional analysis of two novel CYP21A2 missense mutations (p.R224W and p.D407N) was performed.

Design: Our study was composed of two Italian patients suffering from a very mild form of nonclassic CAH (NC-CAH). To assay the enzymatic activity of mutants, the in vitro analysis was performed in transiently transfected COS-1 cells.

Results: The residual activities obtained for p.R224W and p.D407N mutants allow their classification as NC-CAH mutations. These results correlate with the rate of severity of the patients' disease.

Conclusions: In this paper, we report two novel CYP21A2 mutations in two Italian individuals affected by 21-hydroxylase deficiency. Based on the functional in vitro analysis we can classify these mutations as NC-CAH variants.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Hyperplasia, Congenital / enzymology
  • Adrenal Hyperplasia, Congenital / genetics*
  • Adult
  • Amino Acid Sequence
  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • DNA Mutational Analysis
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation, Missense
  • Sequence Alignment
  • Steroid 21-Hydroxylase / genetics*
  • Steroid 21-Hydroxylase / metabolism

Substances

  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase